Kyverna ‘resetting conversation’ with 1-year miv-cel data as autoimmune CAR-T peers hit safety snags Read more 

Lilly puts up $100M, plus billions on the backend, to form 5-target deal with China's InnoCare Read more 

Enveda reaps $311M series E to feed ambition to become a ‘household name’ Read more 

About Charles Muriuki

This author has not yet filled in any details.
So far Charles Muriuki has created 2 blog entries.
Go to Top